Today, we announced our Q4 and Full Year 2024 Financial Results and provided a corporate update. https://lnkd.in/eZ7wqAdc
Lyra Therapeutics
生物技术研究
Watertown，Massachusetts 8,287 位关注者
Clinical-stage biotechnology company developing innovative therapies for the localized treatment of CRS
关于我们
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities. Building on expertise in materials science, drug development and formulation, Lyra has developed proprietary technology that is designed to deliver medicines directly precisely and consistently to the affected tissue for sustained periods with a single administration. Our product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, in-office procedure and intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages for the treatment of CRS.
- 网站
-
https://www.lyratx.com
Lyra Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Watertown，Massachusetts
- 类型
- 上市公司
- 创立
- 2018
- 领域
- Pharmaceuticals和Biotechnology
地点
-
主要
获取路线
480 Arsenal St
US，Massachusetts，Watertown，02472
Lyra Therapeutics员工
动态
-
This #EmployeeAppreciationDay, we're thankful for our employees who are continuing to support our ongoing efforts to evaluate a potential new therapy for CRS.
-
-
Today, we announced our Q3 2024 Financial Results and provided a corporate update. https://lnkd.in/eruMKHTJ
-
-
Today we announce that the pivotal Phase 3 ENLIGHTEN 2 clinical trial of LYR-210 in adult patients with CRS who have not had prior ethmoid sinus surgery is fully enrolled. Topline results from ENLIGHTEN 2 are expected in Q2 2025. https://lnkd.in/evjRidGB
-
-
Today, we announced our Q2 2024 Financial Results and provided a corporate update.? https://lnkd.in/eRZAcuMi
-
-
?? Cellino is #hiring! We have two incredible opportunities for new team members to join us in building an autonomous biomanufacturing platform to scale production of personalized regenerative medicines. Our team is seeking a driven and experienced Therapeutic Pipeline Associate and Product Manager in Advanced Biomanufacturing Technology. The Therapeutic Pipeline Associate will focus on developing frameworks for potential therapeutic programs, while the Product Manager will guide the development of Cellino’s advanced biomanufacturing technology. Both roles will play a critical part on the product team and report to our Co-Founder & Chief Product Officer, Marinna Madrid, PhD. ?? Our team is located in #CambridgeMA and is at the forefront of personalized regenerative medicine! Apply now, or share this link:? https://bit.ly/4bwSEwA? ?? #GreaterBoston #BostonJobs #LifeSciences #Biotech #Biotechnology #Innovation #Autologous? #AI #MachineLearning #RegenMed #PersonalizedMedicine #STEMCareers #YourCellsYourCure #CellinoBio
-
For anyone hiring biotech talent…it has been a difficult week at Lyra Therapeutics, having announced a restructuring that has resulted in having to say goodbye to 80+ valued colleagues after failing to meet our Phase 3 primary endpoint.?These are talented and dedicated professionals. If you are hiring, please comment below or reach out privately.?Resume book coming soon.? ?
-
Today, we announced our Q1 2024 Financial Results and provided a corporate update. https://lnkd.in/eJW6NXF6
-
-
This #AdministrativeProfessionalsDay, we thank the hardworking admin professionals at Lyra and beyond who keep everything organized!
-